In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Histogenics Corporation. Trade Record

NASDAQ:HSGX Histogenics Corporation stock gains 16.68% Exit Jun 19, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart HSGX Jun 1, 2018, priceSeries
About Histogenics Corporation

Histogenics Corporation, a regenerative medicine company, focuses on developing and commercializing products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans. Histogenics Corporation was founded in 2000 and is headquartered in Waltham, Massachusetts.

Trade Information
Trade Type
LONG
ReliabilityScore™
90.48
Entry Date
Jun 1, 2018
Entry Price
2.35
Sell Date
Jun 19, 2018
Sell Price
2.74
Net Gain
16.68%
Hold Time
12 Trading Days